Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

118 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2020.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,437,747 shares of 45,101,565 outstanding shares and own 47.53% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2,655,052 shares), BlackRock Inc. (2,345,757 shares), Sofinnova Investments, Inc. (2,194,278 shares), Cormorant Asset Management, LP (1,397,700 shares), VANGUARD GROUP INC (1,244,290 shares), FMR LLC (1,114,642 shares), STATE STREET CORP (1,049,936 shares), ALLIANCEBERNSTEIN L.P. (959,516 shares), LOOMIS SAYLES & CO L P (788,936 shares), and GOLDMAN SACHS GROUP INC (726,117 shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.